Dermira Takes in $35M in Funding to Enhance Pipelin
By Marie Powers
Tuesday, June 11, 2013
Privately held Dermira Inc. lifted its veil of silence, at least partially, to disclose $35 million in new funding. The infusion came in a Series B financing that included Japanese dermatology specialist Maruho Co. Ltd., of Osaka, and existing investors Bay City Capital, New Enterprise Associates and Canaan Partners as well as a "related transaction" that CEO Tom Wiggans coyly sidestepped.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.